COVID-19: what the clinician should know about post-mortem findings

Intensive Care Med. 2021 Jan;47(1):86-89. doi: 10.1007/s00134-020-06302-0. Epub 2020 Nov 3.

Danny Jonigk^{1

2}, Bruno Märkl³, Julie Helms^{4

5}

¹ Institute of Pathology, Hannover Medical School, Hannover, Germany.
² Member of the German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
³ General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
⁴ Service de Médecine Intensive-Réanimation, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, 1, place de l'Hôpital, 67091, Strasbourg cedex, France. Julie.helms@chru-strasbourg.fr.
⁵ ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, LabEx TRANSPLANTEX, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Fédération Hospitalo-Universitaire (FHU) OMICARE, Université de Strasbourg (UNISTRA), Strasbourg, France. Julie.helms@chru-strasbourg.fr.

No abstract available

Publication types